JP2022545836A5 - - Google Patents
Info
- Publication number
- JP2022545836A5 JP2022545836A5 JP2022513571A JP2022513571A JP2022545836A5 JP 2022545836 A5 JP2022545836 A5 JP 2022545836A5 JP 2022513571 A JP2022513571 A JP 2022513571A JP 2022513571 A JP2022513571 A JP 2022513571A JP 2022545836 A5 JP2022545836 A5 JP 2022545836A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- salt
- composition according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891706P | 2019-08-26 | 2019-08-26 | |
| US62/891,706 | 2019-08-26 | ||
| PCT/US2020/047767 WO2021041392A1 (en) | 2019-08-26 | 2020-08-25 | Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino compounds useful as jak1 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545836A JP2022545836A (ja) | 2022-10-31 |
| JP2022545836A5 true JP2022545836A5 (enExample) | 2023-09-06 |
| JP7671738B2 JP7671738B2 (ja) | 2025-05-02 |
Family
ID=74685810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513571A Active JP7671738B2 (ja) | 2019-08-26 | 2020-08-25 | Ｊａｋ１阻害剤として有用な置換（７ｈ－ピロロ［２，３－ｄ］ピリミジン－４－イル）アミノ化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12492204B2 (enExample) |
| EP (1) | EP4021452B1 (enExample) |
| JP (1) | JP7671738B2 (enExample) |
| CN (1) | CN114761011B (enExample) |
| AU (1) | AU2020338043B2 (enExample) |
| CA (1) | CA3152021A1 (enExample) |
| ES (1) | ES2974946T3 (enExample) |
| PL (1) | PL4021452T3 (enExample) |
| WO (1) | WO2021041392A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12492204B2 (en) * | 2019-08-26 | 2025-12-09 | Chemwerth, Inc. | Substituted (7H-pyrrolo[2,3-D]pyrimidin-4-yl) amino compounds useful as JAK 1 inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009241469B2 (en) * | 2008-04-30 | 2015-05-07 | National Health Research Institutes | Fused bicyclic pyrimidine compounds as Aurora kinase inhibitors |
| AU2010308028A1 (en) | 2009-10-15 | 2012-04-19 | Pfizer Inc. | Pyrrolo[2,3-d] pyrimidine compounds |
| JP6075736B2 (ja) * | 2011-12-21 | 2017-02-08 | ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． | ピロール−６員ヘテロアリール環誘導体、その合成法およびその医薬用途 |
| RU2699034C1 (ru) * | 2016-02-16 | 2019-09-03 | ЗОИТИС СЕРВИСЕЗ ЭлЭлСи | Способ получения соединений 7H-пирроло[2,3-d]пиримидина |
| JP6944496B2 (ja) * | 2018-10-22 | 2021-10-06 | ファイザー・インク | ピロロ［２，３−ｄ］ピリミジントシル酸塩、その結晶形態、ならびにその製造方法および中間体 |
| US12492204B2 (en) * | 2019-08-26 | 2025-12-09 | Chemwerth, Inc. | Substituted (7H-pyrrolo[2,3-D]pyrimidin-4-yl) amino compounds useful as JAK 1 inhibitors |
-
2020
- 2020-08-25 US US17/638,074 patent/US12492204B2/en active Active
- 2020-08-25 CN CN202080074639.8A patent/CN114761011B/zh active Active
- 2020-08-25 ES ES20858240T patent/ES2974946T3/es active Active
- 2020-08-25 PL PL20858240.3T patent/PL4021452T3/pl unknown
- 2020-08-25 CA CA3152021A patent/CA3152021A1/en active Pending
- 2020-08-25 WO PCT/US2020/047767 patent/WO2021041392A1/en not_active Ceased
- 2020-08-25 AU AU2020338043A patent/AU2020338043B2/en active Active
- 2020-08-25 JP JP2022513571A patent/JP7671738B2/ja active Active
- 2020-08-25 EP EP20858240.3A patent/EP4021452B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018203354B2 (en) | Hepatitis B antiviral agents | |
| EP3740487B1 (en) | Benzamide compounds as bci inhibitors for the treatment of hiv | |
| AU2014348518B2 (en) | Azepane derivatives and methods of treating hepatitis B infections | |
| JP7090100B2 (ja) | 疼痛の処置のための１１，１３－修飾サキシトキシン： | |
| CN103249697B (zh) | 适用作多巴胺能稳定剂的普利多匹定(pridopidine)氘化类似物 | |
| CN104884434B (zh) | 用于治疗病毒感染和另外的疾病的酰氨基嘧啶衍生物 | |
| EP2997019B1 (en) | Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b | |
| DK2585467T3 (en) | PYRAZOLO [1,5-A] PYRIMIDINES AND TRIAZINES AS ANTIVIRAL AGENTS | |
| ES2654173T3 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| WO2017106226A1 (en) | Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels | |
| JP7159440B2 (ja) | ジカチオン化合物及びその製造方法と使用 | |
| CA2891342A1 (en) | Novel orally bioavailable breathing control modulating compounds, and methods of using same | |
| WO2019129216A1 (zh) | 一种吡啶基咪唑并苯并二氮杂卓丙酸酯化合物及其合成和应用 | |
| US20230112832A1 (en) | Chemokine CXCR4 Receptor Modulators and Uses Related Thereto | |
| TWI924820B (zh) | 1,3-取代的環丁基衍生物及其用途 | |
| CN104650070A (zh) | 二氢嘧啶类化合物及其在药物中的应用 | |
| CN109422668B (zh) | 一种长效雷沙吉兰前药及其制备方法和用途 | |
| EP2890687B1 (en) | Salts of benzothiazolone compound as beta-2-adrenoceptor agonist | |
| RU2778455C2 (ru) | 11,13-модифицированные сакситоксины для лечения боли | |
| HK40040853B (en) | Benzamide compounds as bci inhibitors for the treatment of hiv | |
| HK40040853A (en) | Benzamide compounds as bci inhibitors for the treatment of hiv | |
| CN104447584A (zh) | 含有环丁烷取代基的吡嗪类化合物及其组合物及用途 | |
| NZ625614B2 (en) | Hepatitis b antiviral agents | |
| HK1197550A (en) | Hepatitis b antiviral agents | |
| HK1197550B (en) | Hepatitis b antiviral agents |